5-Hydroxytryptamine (5-HT)
receptors belong to the 'Cys-loop receptor' superfamily, which also includes nicotinic acetylcholine (nACh) receptors, g-aminobutyric acid type A (GABA A ) receptors and glycine receptors. [1] [2] [3] [4] The 5-HT 3 receptors are distributed throughout the central nervous system (CNS) and the peripheral nervous system (PNS), with strongest expression found in the nucleus tractus solitarius, area postrema and dorsal motor nucleus of the vagus nerve, where they play an important role in the initiation and coordination of the vomiting reflex. 5, 6) In the CNS, postsynaptic 5-HT 3 receptors mediate the fast synaptic response to serotonin, and presynaptic receptors regulate the synaptic release of serotonin and several other neurotransmitters. 7, 8) Also, the 5-HT 3 receptors are established drug targets. For examples, competitive antagonists targeting central and gastrointestinal 5-HT 3 receptors are used in the clinical treatment of the nausea and/or emesis associated with radio-and chemotherapy treatment of cancer, postoperative nausea and vomiting, and irritable bowel syndrome. 9, 10) Furthermore, central 5-HT 3 receptors have been proposed as potential targets for the treatment of various psychiatric disorders, cognitive dysfunction, drug abuse and withdrawal, and certain forms of pain. 10) Proanthocyanidin is a kind of phenolic compound (oligonols are catechin-type monomers, dimmers and trimers, as well as oligomeric proanthocyanidins) present in plants, especially highly present in the grape seed, that has received attention recently. 11, 12) Experimental and clinical studies have revealed that proanthocyanidin has antioxidant, antinociceptive, anti-emetic, and cardioprotective properties, without inducing significant toxicological effects. [13] [14] [15] [16] In view of the above reports, we try to investigate whether proanthocyanidin has any effects on the activity of 5-HT 3 receptors. Accordingly, we tested the effects of proanthocyanidin on 5-HT 3 receptor function using patch-clamp recording combined with a fast drug application technique in order to explore a new pharmacological mechanism for the effect of proanthocyanidin.
MATERIALS AND METHODS
Materials NCB-20 neuroblastoma cells were kindly provided by Dr. Lovinger (National Institute on Alcohol Abuse and Alcoholism, U.S.A.). Proanthocyanidin was purchased from InterHealth Nutraceuticals Inc. (Benicia, CA, U.S.A.), as a grape seed proanthocyanidin extract (GSPE) containing approximately 76% oligomeric proanthocyanidins and 3% monomeric bioflavonoids. Cell culture reagents were obtained from Gibco BRL (Rockville, MD, U.S.A.). Serotonin and all other chemicals were purchased from Sigma Chemicals (St. Louis, MO, U.S.A.).
Cell Culture NCB-20 cells were maintained under conditions previously described. 17) Frozen cell stocks were maintained in liquid nitrogen, and thawed as needed. Cells were routinely grown in medium containing 90% Dulbecco's modified Eagle's medium, which contained 3.7 g/l NaHCO 3 (pH adjusted to 7.4 with NaOH), 10% fetal bovine serum, and 1% hypoxanthine aminopterin thymidine supplement (HAT, which gave a final concentration of 13.6 mg/l hypoxanthine, 0.178 mg/l aminopterin, and 3.88 mg/l thymidine) and were cultured in an incubator containing 5% CO 2 at 37°C. Cells were seeded onto 35-mm culture dishes at least 2 d prior to electrophysiological experiments.
Electrophysiological Recordings Whole-cell patchclamp recordings were performed in 35-mm culture dishes at room temperature (21-24°C) on the stage of an inverted microscope (TS 100; Nikon, Tokyo, Japan), as described previously. 17) Cells were continuously superfused with an extracellular solution containing 150 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl 2 , 10 mM N-(2-hydroxyethyl)piperazine-NЈ-2-ethanesulfonic acid (HEPES), and 10 mM D-glucose (pH adjusted to 7.4 with NaOH and osmolality adjusted to 340 mOsm/kg with sucrose) at a rate of 2-3 ml/min. Patch pipettes were pulled from thin-walled borosilicate glass tubing (Molecular Devices, Inc. Sunnyvale, CA, U.S.A.) with a filament using a puller (P-97; Sutter instrument Co., Novato, CA, U.S.A.). Pipette tips had resistances of 2.0-3.0 MW when filled with an internal solution containing 140 mM CsCl, 2 mM MgCl 2 , 5 mM ethylene glycol bis(2-aminoethylether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA), and 10 mM HEPES (pH adjusted to 7.4 with CsOH, osmolality adjusted to 310 mOsm/kg with sucrose). Whole-cell currents were amplified using an EPC-7 patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany) and saved on a PC using DigiData1322 and pClamp 9.0 software (Molecular Devices, Inc.). All experiments were carried out at a holding potential of Ϫ50 mV unless otherwise stated. Currents were filtered at 10 kHz using a three-pole Bessel filter and digitized at 10 kHz. Capacitive currents were compensated with analog compensation, but leak subtraction was not used in this study.
Drug Preparation and Application After establishing a whole-cell configuration, the cell was lifted and placed in front of one side of a q-tubing pipette, which had been pulled to an inner diameter of ca. 300 mm. The extracellular solution, which contained the agonist, flowed through a different side of the q-tubing. Solutions were rapidly switched around the cell using a piezo-electric translator (P-287.70; Physik Instrument, Waldbronn, Germany), which displaced the q-tubing laterally so that the cell could be exposed for a defined period of time to the drug-containing solution, and then rapidly returned to the drug-free solution. The piezo-electric translator was controlled by a high-voltage amplifier (E-507; Physik Instrumente) and triggered by pClamp 9.0 software (Molecular Devices, Inc.). The rate of solution exchange was usually 24.4Ϯ5.3 ms (nϭ11) in the open pipette tip configuration. 17) Solution flow was driven by gravity from wells placed above the preparation, and the application of the solutions was controlled by a valve placed upstream of the drugcontaining tubing. Immediately after achieving a whole-cell configuration, a variable amount of current run-down was typically observed. However, the currents stabilized 20 min after achieving whole-cell mode. During the experiment, drug applications and current recordings were carried out at 2 min intervals to minimize any effects of desensitization. Because the effect of proanthocyanidin was irreversible, the cell had to be changed after a one time application of proanthocyanidin to exclude the possibility of a carry-over effect. Serotonin and proanthocyanidin were diluted in the extracellular solution from stock solutions before use. Since proanthocyanidin was dissolved in dimethyl sulfoxide (DMSO), appropriate amounts of this solvent (usually no more than 0.1% in the final volume) were added to control experiments, and these concentrations of DMSO do not affect the experimental results.
Data Analysis Peak current amplitudes were measured using Clampfit 9.0 software (Molecular Devices, Inc.) by determining the difference in current at time points set by cursors positioned to measure the current prior to the onset of agonist application and at the peak current during agonist application. We also analyzed the 10-90% rise slope (the slope to increase from 10 to 90% of the peak current) using the built-in statistical tools in Clampfit 9.0 software, which are commonly used to determine current activation. Receptor desensitization was measured as the decay in the agonistinduced response in the continuous presence of agonist. The decay time constants for desensitized currents were calculated by monoexponential fits using Clampfit 9.0 software. Since peak current amplitudes, rise slope and the decay time induced by agonist application varied between different cells, these values were normalized to maximal values in each cell. Because the proanthocyanidin effect was irreversible and the cell was changed after each application of proanthocyanidin, its inhibitory effect was expressed as the effect normalized to the control current induced by 5-HT alone, which was taken as 100%.
Prism 4.0 software (GraphPad Software, San Diego, CA, U.S.A.) was used to create graphics. The concentration-response curves for 5-HT were fitted to a sigmoid curve, as calculated by the four-parameter logistic equation:
where bottom is the baseline response, top is the maximal response, X is the logarithm of the concentration, and IC 50 is the concentration of proanthocyanidin resulting in 50% inhibition.
All averaged values are presented as meansϮS.E.M. Statistical significance was determined by Student's t-test. The criterion for statistical significance was pϽ0.05.
RESULTS

Effect of Proanthocyanidin on 5-HT-Induced Currents
Lambert et al. 18) reported that application of 5-HT to NCB-20 cells produced ion current exclusively via 5-HT 3 receptor activation. This conclusion was based on the potent blockade of the response observed with GR 38032F and ICS 205-930, the 5-HT 3 receptor antagonists. 18) In our study, we firstly determined the concentration-response relationship for the effects of 5-HT on 5-HT 3 receptor-mediated currents. The application of 0.1-300 mM 5-HT for 5 s at 2 min intervals to NCB-20 cells caused a concentration-dependent inward current at Ϫ50 mV, and 30 mM 5-HT induced a near-maximal response. The EC 50 value was 2.7Ϯ0.4 mM, with a Hill coefficient of 2.1Ϯ0.1 (Fig. 4A) . The characteristics of 5-HTinduced ion currents were similar to those in our previous reports. 17, 19) We tested the concentration-dependent effects of proanthocyanidin on the currents evoked by 3 mM 5-HT (near EC 50 ). Application of 0.3-100 mg/ml proanthocyanidin in the absence of 5-HT did not induce any currents (the effect of treatment of 100 mg/ml proanthocyanidin alone shown in Fig.  1A ). Co-treatment with proanthocyanidin and 5-HT produced a small inhibition, although statistically significant at high concentrations (м30 mg/ml) of proanthocyanidin, on 5-HT-induced inward peak current (I 5-HT ) with the maximal inhibition of 9.89Ϯ1.2% in 100 mg/ml proanthocyanidin (nϭ6, pϽ0.01, when compared to control) (Fig. 1B) . However, pretreatment of cells with proanthocyanidin for 30 s before application of 5-HT greatly inhibited I 5-HT in a concentrationdependent manner. Representative traces are shown in Fig.  1A and Fig. 2A . Figure 1B illustrates concentration-response curves for proanthocyanidin-induced inhibition when it was used to pre-treat cells for 30 s or when it was co-applied with 5-HT. The IC 50 for inhibition of I 5-HT when the cell was preexposed to proanthocyanidin for 30 s was 6.5Ϯ0.4 mg/ml and the Hill coefficient was 2.5Ϯ0.1 (nϭ6). After inhibition with different concentrations of proanthocyanidin, washout studies showed partial (20-30%) recovery from proanthocyanidin inhibition over 15 min. Extended time studies showed about 50% recovery from proanthocyanidin inhibition at 1h (data not shown). Thus, the effect of proanthocyanidin on 5-HT-induced currents seems to be irreversible, which makes it necessary to change the cell after its exposure to proanthocyanidin every time.
Drug Application Mode-and Time-Dependent Inhibition of I 5-HT by Proanthocyanidin As shown in Fig. 1 , pretreatment of proanthocyanidin before 5-HT application produced much stronger inhibition than did co-application with 5-HT. We further investigated the inhibitory effect of proanthocyanidin (5 mg/ml, near IC 50 for 3 mM 5-HT-induced currents) on I 5-HT using three different drug application modes: (1) simultaneous exposure of the cell to proanthocyanidin and 5-HT (co-application); (2) pre-exposure to proanthocyanidin before 5-HT but no co-application with 5-HT; (3) continuous exposure to proanthocyanidin before and during application of 5-HT (Fig. 2A) . The proanthocyanidin had no significant effect on I 5-HT when it was applied simultaneously with 3 mM 5-HT, while the inhibition by proanthocyanidin was pronounced when the drug was exclusively applied 30 s prior to agonist-induced activation of the 5-HT 3 receptors and an equally high inhibition was seen when proanthocyanidin was applied both 30 s before and during 5-HT application. The effects of proanthocyanidin from the above three drug application modes can be expressed as % of control values of 98.0Ϯ0.8 ( pϭ0.238), 72.7Ϯ3.7 (pϽ0.001) and 71.2Ϯ3.0 (pϽ0.001), respectively (nϭ7). Unlike the weak inhibition found during the first drug application mode, proanthocyanidin caused marked inhibition of I 5-HT following the second and the third drug application mode, and there were no significant difference between the second and the third drug application mode ( pϭ0.806, nϭ7) (Fig. 2B) . Thus, the second drug application method was adopted in all subsequent studies. Figure 2C shows the time-dependent relationship for inhibition of I 5-HT by 5 mg/ml proanthocyanidin. Cells were pretreated with proanthocyanidin for 5, 10, 30, 60, or 120 s before 5-HT was applied. The data indicate that proanthocyanidin produced negligible inhibition of I 5-HT when it was preapplied for less than 10 s before 5-HT application, while inhibitory effects were nearly same after 30 s; maximal inhibition occurred after 1 min of pretreatment. Proanthocyanidin inhibited I 5-HT by 1.8Ϯ1.3, 4.2Ϯ1.0, 30.1Ϯ3.0, 39.7Ϯ4.5, and 42.7Ϯ2.6% after 5, 10, 30, 60, and 120 s pretreatment, respectively, before 5-HT application. As 30 s pre-exposure to proanthocyanidin produced a near-maximal inhibition of I 5-HT , this protocol was used in all subsequent experiments.
Effect of Proanthocyanidin on 5-HT 3 Receptor Activation and Desensitization For these experiments, a concen- (Fig. 3A) . Figure 3B shows the concentration-dependent inhibition of peak currents evoked by 30 mM 5-HT at different concentrations of proanthocyanidin (the IC 50 was 22.1Ϯ0.4 mg/ml, and the Hill coefficient was 2. 4Ϯ0.1, nϭ7) . In addition, pretreatment of cells with proanthocyanidin for 30 s significantly decreased the rise slope of 5-HT-induced currents at concentrations м3 mg/ml, giving % of control values of 93.9Ϯ0.8 (pϽ0.01), 59.6Ϯ2.8 (pϽ0.001), 10.1Ϯ1.1 ( pϽ0.001) and 4.1Ϯ0.3 (pϽ0.001) at proanthocyanidin concentrations of 3, 10, 30, and 100 mg/ml, respectively (nϭ7). Meanwhile, proanthocyanidin significantly prolonged the current decay time constant (t off ) at concentrations higher than 30 mg/ml, with % of control values of 198.3Ϯ22.0 (pϽ0.01) and 245.1Ϯ13.6 (pϽ0.001) when cells were pretreated with 30 and 100 mg/ml proanthocyanidin for 30 s, respectively (nϭ7). These effects of proanthocyanidin on both activation and desensitization of 5-HT 3 receptors showed obvious concentration-dependency (Figs. 3C, D) .
Noncompetitive Inhibition of 5-HT 3 Receptors by
Proanthocyanidin To evaluate the mechanism by which proanthocyanidin inhibits I 5-HT , we analyzed the effect of 20 mg/ml proanthocyanidin (which is near the IC 50 for inhibition of the effects of 30 mM 5-HT, Fig. 3B (Fig. 4B) . Proanthocyanidin inhibited I 5-HT by 48.4Ϯ2.1, 47.8Ϯ2.4, 48.8Ϯ3.4, 44.5Ϯ2.7, 46.0Ϯ1.6, and 39.5Ϯ3.1% at Ϫ50, Ϫ30, Ϫ10, 0, ϩ10, and ϩ30 mV membrane holding potentials, respectively (nϭ6).
DISCUSSION
In the present study, we demonstrated the effects of proanthocyanidin, a major active component of grape seed extracts, on the function of 5-HT 3 receptors in NCB-20 cells. The function of these receptors was assessed by measuring the current induced by fast application of 5-HT under voltage-clamp conditions. The effects of proanthocyanidin on both I 5-HT and the kinetics of activation and desensitization of 5-HT 3 receptors were studied.
Co-application of 0.3-100 mg/ml proanthocyanidin produced a less than 10% reduction of I 5-HT induced by 3 mM 5-HT, while pretreatment of cells with proanthocyanidin for 30 s before 5-HT application caused much stronger inhibition; under the latter conditions, the concentration dependence of the inhibition was apparent. The inhibitory effect of proanthocyanidin also showed a dependency on pretreatment time. These results suggest that proanthocyanidin is acting on a closed state of the receptor, or that the effect of proanthocyanidin is slower than the typical opening and closing kinetics of 5-HT 3 receptor currents 20, 21) as has been shown in our study: co-application of proanthocyanidin with 5-HT did not produce remarkable inhibitory effect because proanthocyanidin needs around 30 s to express its inhibitory effect and this time is too late to inhibit 5-HT-induced current whose peak appears in less than 0.5 s.
On the other hand, pretreatment with proanthocyanidin affected the kinetics of 5-HT 3 receptors. At concentrations м3 mg/ml, proanthocyanidin caused a pronounced concentration-dependent decrease of the rise slope of 5-HT-induced currents. At higher concentrations (м30 mg/ml), proanthocyanidin produced a significant deceleration of the current decay time constant (t off ), which was also concentration dependent. Therefore, the data indicate that proanthocyanidin mainly produces a strong inhibition of activation at lower concentrations and inhibits the desensitization of 5-HT 3 receptors at higher concentrations.
We studied the mechanism by which proanthocyanidin inhibits 5-HT 3 receptors by measuring the effect of 20 mg/ml proanthocyanidin on the peak currents induced by different concentrations of 5-HT. In these competition experiments, we observed that the presence of proanthocyanidin caused a rightward shift of the dose-response curve without significantly changing the Hill coefficient. At the same time, the peak amplitude of the control current was inhibited consistently and the inhibitory effect was not relieved even at high 5-HT concentrations. All these results indicate a noncompetitive inhibitory mechanism of proanthocyanidin of the 5-HT 3 receptors. Prior studies suggested that proanthocyanidin is membrane-impermeable because of its size and polarity and that it seems unlikely that it is transported across the membrane at a sufficient rate to reach a potential intracellular target. 22, 23) Thus, the noncompetitive inhibition of 5-HT 3 receptor channel activity by proanthocyanidin indicates that proanthocyanidin has different binding or interaction sites through which it modulates the 5-HT 3 ion channel from the extracellular side.
Our data and the above reports 22, 23) suggest that proanthocyanidin inhibits 5-HT 3 receptors in a noncompetitive manner, and that there exits the possibility that proanthocyanidin acts as an open channel blocker at 5-HT 3 receptors. Therefore, we tested the voltage dependency of the inhibition by proanthocyanidin by measuring its effect on current-voltage relationships. As shown in Fig. 4B , the inhibition produced by proanthocyanidin was observed both at negative voltages and positive voltages and had a similar magnitude. These results indicate that proanthocyanidin might not act as an open channel blocker since inhibition by proanthocyanidin was not voltage dependent, whereas inhibition by open channel blockers shows strong voltage dependence owing to the charge they possess in a transmembrane electrical field. [24] [25] [26] From the present study, we have demonstrated that (1) pretreatment of cells with proanthocyanidin before application of 5-HT causes much stronger inhibition of I 5-HT in NCB-20 cells than does co-application with 5-HT. The inhibition is irreversible and dose dependent; (2) at high concentrations, proanthocyanidin also inhibits the activation and desensitization of 5-HT 3 receptors in a dose-dependent manner; (3) inhibition of I 5-HT by proanthocyanidin is noncompetitive and voltage independent. The results of several studies have shown that proanthocyanidin has antinociceptive and antiemetic actions although the precise mechanism is unclear. 11, 13, 16) On the other hand, the 5-HT 3 receptors mediate emesis and pain, 27, 28) and some antagonists of the 5-HT 3 receptors, like ondansetron, have been shown to prevent the development of pain and emesis. [29] [30] [31] [32] In addition, some antiemetic drugs like metoclopramide have been reported to be potent antagonists of 5-HT 3 receptors. 21) Taken together, these findings suggest the possibility that proanthocyanidinmediated regulation of 5-HT 3 receptors is therapeutically relevant although we currently do not have direct evidence that proanthocyanidin can be used as a therapeutic agent for the alleviation of 5-HT 3 receptor-related clinical symptoms such as vomiting and pain. To confirm this possibility, further studies are required to provide more insight into the effects and toxicity of proanthocyanidin in animals and humans.
Proanthocyanidin used in the present study was derived from grape seeds extract which also contains 3% monomeric bioflavonoids. Indeed, we consider that the inhibitory effects on 5-HT 3 receptors mainly result from the oligomeric proanthocyanidins. However, like most other studies using this compound, our study cannot completely exclude the possible role of monomeric bioflavonoids although their contents are very low.
